Cargando…
Botulinum toxin and occlusal splints for the management of sleep bruxism in individuals with implant overdentures: A randomized controlled trial
BACKGROUND: The available treatment options fail to provide definitive or curative management for bruxer patients rehabilitated with implant overdentures (OD). The data regarding Botulinum toxin (BTX) injection as a management strategy for bruxism remains unclear. This randomized, single-blinded, co...
Autores principales: | Ali, Samer Mostafa, Alqutaibi, Ahmed Yaseen, Aboalrejal, Afaf, Elawady, Dina Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665162/ https://www.ncbi.nlm.nih.gov/pubmed/34938043 http://dx.doi.org/10.1016/j.sdentj.2021.07.001 |
Ejemplares similares
-
Saliva May Be Considered as Reliable Tool for Diagnosis of COVID-19 When Compared With Nasopharynx or Throat Swabs
por: Alqutaibi, Ahmed Yaseen, et al.
Publicado: (2021) -
Efficacy of botulinum toxin in the management of temporomandibular myofascial pain and sleep bruxism
por: Hosgor, Hatice, et al.
Publicado: (2020) -
Finite element analysis of occlusal splint therapy in patients with bruxism
por: Gholampour, Seifollah, et al.
Publicado: (2019) -
Computerized analysis of occlusal contacts in bruxism patients treated with occlusal splint therapy
por: Gümüş, Hasan Önder, et al.
Publicado: (2013) -
Does the facebow affect the outcome of CAD/CAM occlusal splint. Randomized clinical trial
por: Alqutaibi, Ahmed Yaseen, et al.
Publicado: (2021)